Form D · Biotechnology
PROCARE DIAGNOSTICS LLC
Boca Raton, FL · CIK 0001684895
Offering snapshot reported Oct 4, 2016 · SEC filing
- Reported sold
- $58K Offering amount: $200K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 16, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 4, 2016 | Initial | $58,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-271807
Sale of Class A Units of Issuer.
Source: Form D, filed Oct 4, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Navroze Mehta | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
123 Nw 13 Th Street, Ste 307
Boca Raton, FL, 33432
Boca Raton, FL, 33432